Literature DB >> 7806688

Relationship of lithium concentrations in the brain measured by lithium-7 magnetic resonance spectroscopy to treatment response in mania.

T Kato1, T Inubushi, S Takahashi.   

Abstract

Lithium concentrations in the brain were measured in 14 manic patients with bipolar disorder (12 with bipolar disorder, manic, and 2 with bipolar disorder, not otherwise specified, by DSM-III-R) by the use of lithium-7 magnetic resonance spectroscopy ([7Li]MRS). The reduction of Petterson Mania Rating Scale 4 weeks after the initiation of lithium treatment was not significantly correlated with concentrations in serum (r = 0.33), but was correlated with concentrations in the brain (r = 0.64; p < 0.05). These results suggest that the treatment response to lithium in manic patients with bipolar disorder is more closely related to the lithium concentration in the brain as measured by [7Li]MRS than to the concentration in serum.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7806688

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  8 in total

1.  A pilot fMRI study of lithium response in bipolar disorder.

Authors:  Kelly Rootes-Murdy; Kara Glazer; Francis M Mondimore; Fernando S Goes; Peter P Zandi; Arnold Bakker; J Raymond DePaulo; Pamela B Mahon
Journal:  Psychiatry Res Neuroimaging       Date:  2019-02-21       Impact factor: 2.376

Review 2.  Metabolism and excretion of mood stabilizers and new anticonvulsants.

Authors:  T A Ketter; M A Frye; G Corá-Locatelli; T A Kimbrell; R M Post
Journal:  Cell Mol Neurobiol       Date:  1999-08       Impact factor: 5.046

Review 3.  Lithium in bipolar disorder: can drug concentrations predict therapeutic effect?

Authors:  Beth Sproule
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 4.  Drug Interactions with Lithium: An Update.

Authors:  Patrick R Finley
Journal:  Clin Pharmacokinet       Date:  2016-08       Impact factor: 6.447

5.  Mesocortical BDNF signaling mediates antidepressive-like effects of lithium.

Authors:  Di Liu; Qian-Qian Tang; Di Wang; Su-Pei Song; Xiao-Na Yang; Su-Wan Hu; Zhi-Yong Wang; Zheng Xu; He Liu; Jun-Xia Yang; Sarah E Montgomery; Hongxing Zhang; Ming-Hu Han; Hai-Lei Ding; Jun-Li Cao
Journal:  Neuropsychopharmacology       Date:  2020-05-19       Impact factor: 7.853

Review 6.  Neurochemical predictors of response to pharmacologic treatments for bipolar disorder.

Authors:  Melissa P Delbello; Stephen M Strakowski
Journal:  Curr Psychiatry Rep       Date:  2004-12       Impact factor: 8.081

Review 7.  Neuron-glia Interaction as a Possible Pathophysiological Mechanism of Bipolar Disorder.

Authors:  Jairo Vinicius Pinto; Ives Cavalcante Passos; Diego Librenza-Garcia; Grasiela Marcon; Maiko Abel Schneider; Joao Henrique Conte; Joao Pedro Abreu da Silva; Luiza Pereira Lima; Andre Quincozes-Santos; Marcia Kauer-Sant Anna; Flavio Kapczinski
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

8.  3D 7Li magnetic resonance imaging of brain lithium distribution in bipolar disorder.

Authors:  Fiona Elizabeth Smith; Peter Edward Thelwall; Joe Necus; Carly Jay Flowers; Andrew Matthew Blamire; David Andrew Cousins
Journal:  Mol Psychiatry       Date:  2018-02-09       Impact factor: 15.992

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.